Seres Therapeutics, Inc. (MCRB)
NASDAQ: MCRB · Real-Time Price · USD
16.66
-1.24 (-6.93%)
At close: Dec 5, 2025, 4:00 PM EST
16.78
+0.12 (0.72%)
After-hours: Dec 5, 2025, 6:15 PM EST
Seres Therapeutics Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Dec '25 Dec 5, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Market Capitalization | 151 | 142 | 181 | 698 | 765 | 2,236 | |
| Market Cap Growth | 28.27% | -21.59% | -74.06% | -8.81% | -65.78% | 825.56% | |
| Enterprise Value | 188 | 169 | 223 | 541 | 461 | 1,979 | |
| Last Close Price | 16.66 | 16.62 | 28.00 | 112.00 | 166.60 | 490.00 | |
| PE Ratio | 26.91 | 1043.26 | - | - | - | - | |
| PS Ratio | 429.39 | - | - | - | 5.28 | 67.31 | |
| PB Ratio | 3.34 | 10.29 | -4.03 | 64.71 | 5.82 | 12.79 | |
| P/TBV Ratio | 3.45 | 10.29 | - | 64.71 | 5.82 | 12.79 | |
| P/OCF Ratio | - | - | - | - | 114.40 | - | |
| EV/Sales Ratio | 536.55 | - | - | - | 3.18 | 59.60 | |
| Debt / Equity Ratio | 1.95 | 6.65 | -4.43 | 15.08 | 0.37 | 0.23 | |
| Asset Turnover | 0.00 | - | - | - | 0.42 | 0.14 | |
| Quick Ratio | 2.16 | 0.80 | 1.30 | 2.12 | 3.53 | 5.67 | |
| Current Ratio | 2.30 | 0.94 | 1.78 | 2.28 | 3.69 | 5.79 | |
| Return on Equity (ROE) | 15.96% | - | - | -258.04% | -42.83% | -141.00% | |
| Return on Assets (ROA) | -40.12% | -30.43% | -34.48% | -31.96% | -11.55% | -23.17% | |
| Return on Capital (ROIC) | -52.45% | -58.47% | -74.51% | -63.51% | -20.34% | -51.97% | |
| Return on Capital Employed (ROCE) | -85.40% | -123.10% | -75.10% | -68.40% | -23.70% | -29.70% | |
| Earnings Yield | 3.58% | 0.10% | -62.84% | -35.85% | -8.57% | -3.99% | |
| FCF Yield | -15.50% | -105.01% | -69.26% | -34.20% | -0.38% | -4.21% | |
| Buyback Yield / Dilution | -19.92% | -21.40% | -18.44% | -17.86% | -14.93% | -40.85% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.